Implementing Primary Prevention for Peanut Allergy at a Population Level

JAMA. 2017 Mar 21;317(11):1111-1112. doi: 10.1001/jama.2017.0922.

Authors

Paul J Turner¹, Dianne E Campbell²

Affiliations

¹ Section of Paediatrics, Imperial College London, London, United Kingdom2Discipline of Child and Adolescent Health, University of Sydney, Sydney, Australia.
² Discipline of Child and Adolescent Health, University of Sydney, Sydney, Australia3Children's Hospital at Westmead, Sydney, Australia.

PMID: 28192569
DOI: 10.1001/jama.2017.0922

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Age Factors*
Anaphylaxis / etiology
Anaphylaxis / mortality
Eczema / complications
Food Hypersensitivity / diagnosis
Humans
Infant
Intention to Treat Analysis
Medical Overuse
National Institute of Allergy and Infectious Diseases (U.S.)
Peanut Hypersensitivity / complications
Peanut Hypersensitivity / diagnosis
Peanut Hypersensitivity / prevention & control*
Practice Guidelines as Topic*
Pre-Exposure Prophylaxis / methods
Primary Prevention / methods*
Randomized Controlled Trials as Topic
United States

Grants and funding

MR/K010468/1/MRC_/Medical Research Council/United Kingdom